Dr. Stapp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Phone+1 813-745-4673
Summary
- Dr. Robert Stapp is a pathologist in Tampa, FL and is affiliated with Moffitt Cancer Center. He received his medical degree from Kansas City University College of Osteopathic Medicine and has been in practice 10 years. He specializes in anatomic pathology and clinical pathology and is experienced in health technology/informatics, pathology, and information systems.
Education & Training
- Henry Ford HospitalFellowship, Clinical Informatics (Pathology), 2012 - 2014
- Henry Ford Health/Henry Ford HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2012
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2007
Certifications & Licensure
- FL State License 2021 - 2026
- PA State License 2014 - 2022
- MI State License 2007 - 2015
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Clinical Informatics
Publications & Presentations
PubMed
- Problematic Proteins: A Patient with a High Paraprotein Concentration.Glen L Hortin, Robert T Stapp, Shrinjaya B Thapa, Ariel F Grajales-Cruz
Clinical Chemistry. 2024-07-05 - 7 citationsCD8+ and FoxP3+ T-Cell Cellular Density and Spatial Distribution After Programmed Death-Ligand 1 Check Point Inhibition.Joseph Curry, Angela Alnemri, Ramez Philips, Michele Fiorella, Sarah Sussman
The Laryngoscope. 2023-08-01 - 2 citationsVolume Doubling Time of Pulmonary Carcinoid Tumors Measured by Computed Tomography.Douglas H Russ, Julie A Barta, Nathaniel R Evans, Robert T Stapp, Gregory C Kane
Clinical Lung Cancer. 2022-11-01
Journal Articles
- Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.Lehman NL, O'Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, Schultz LR, Williams CJ, Mikkelsen T, Brown SL, Ecsedy JA, Poisson LM, Cell Cycle
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: